deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT01455831

Extended Peri-operative Tinzaparin to Improve Disease-free Survival in Patients With Resectable Colorectal Cancer (PERIOP-01)

A Multicentre Randomized Controlled Trial of the Use of Extended Peri-Operative Low Molecular Weight Heparin to Improve Cancer Specific Survival Following Surgical Resection of Colorectal Cancer

Sponsor: Ottawa Hospital Research Institute

Conditions Adenocarcinoma of the Colon
Interventions Tinzaparin
Updated 9 times since 2017 Last updated: May 14, 2021 Started: Sep 30, 2011 Primary completion: Dec 31, 2020 Completion: Feb 1, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Adenocarcinoma of the Colon and is currently completed. Ottawa Hospital Research Institute leads this study, which shows 9 recorded versions since 2011 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotRecruiting~Jun 2018 – ~Aug 2019 · 14 months · monthly snapshotRecruiting~Aug 2019 – ~Apr 2020 · 8 months · monthly snapshotRecruiting~Apr 2020 – ~Jan 2021 · 9 months · monthly snapshotRecruiting~Jan 2021 – ~Jun 2021 · 5 months · monthly snapshotRecruiting~Jun 2021 – ~Jul 2024 · 37 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 9 months · monthly snapshotCompleted

Change History

9 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  4. Jun 2021 — Jul 2024 [monthly]

    Completed PHASE3

    Status: Recruiting → Completed

  5. Jan 2021 — Jun 2021 [monthly]

    Recruiting PHASE3

▶ Show 4 earlier versions

  1. Apr 2020 — Jan 2021 [monthly]

    Recruiting PHASE3

  2. Aug 2019 — Apr 2020 [monthly]

    Recruiting PHASE3

  3. Jun 2018 — Aug 2019 [monthly]

    Recruiting PHASE3

  4. Jan 2017 — Jun 2018 [monthly]

    Recruiting PHASE3

    First recorded

Sep 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Ottawa Hospital Research Institute
Data source: Ottawa Hospital Research Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations